References
- Volkow ND, Jones EB, Einstein EB, Wargo EM. Prevention and treatment of opioid misuse and addiction: a review. JAMA Psychiatry. 2019;76(2):208–216.
- Leshner AI, Dzau VJ. Medication-based treatment to address opioid use disorder. JAMA. 2019;321(21):2071–2072.
- Donroe JH, Tetrault JM. Narrowing the treatment gap in managing OUD. CMAJ. 2018;190(9):E236–E237.
- Donroe JH, Bhatraju EP, Tsui JI, Eledman EJ. Identification and management of OUD in primary care: an update. Curr Psychiatry Rep. 2020;22(5):23.
- Korthuis PT, McCarty D, Weimer M, et al. Primary care-based models for the treatment of opioid use disorder: a scoping review. Ann Intern Med. 2017;166(4):268–278.
- Department of Vermont Health Access managed care entity. Vermont buprenorphine clinical practice guidelines. 2015. http://dvha.vermont.gov/for-providers/buprenorphine-practice-guidelines-revised-final-10-15.pdf. Accessed April 12, 2017.
- LaBelle CT, Han SC, Bergeron A, Samet JH. Office-based opioid treatment with buprenorphine (OBOT-B): statewide implementation of the massachusetts collaborative care model in community health centers. J Subst Abuse Treat. 2016;60:6–13.
- Boston Medical Center. Policy and Procedure Manual of the Office-Based Addiction Treatment Program for the Use of Buprenorphine and Naltrexone Formulations in the Treatment of Substance Use Disorders. Boston, MA: Boston Medical Center; 2016.
- Unutzer J, Katon W, Callahan CM, et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288(22):2836–2845.
- Archer J, et al. Collaborative care for depression and anxiety problems. Cochrane Database of Systematic Reviews. 2012;(10). DOI: 10.1002/14651858.CD006525.pub2.
- Ghabrash MF, Bahremand A, Veilleux M, et al. Depression and outcomes of methadone and buprenorphine treatment among people with opioid use disorders: a literature review. J Dual Diagn. 2020;16(2):191–207.
- Watkins KE, Ober AJ, Lamp K, et al. Collaborative care for opioid and alcohol use disorders in primary care: the SUMMIT randomized clinical trial. JAMA Intern Med. 2017;177(10):1480–1488.
- Meredith LS, Komaromy MS, Cefalu M, et al. Design of CLARO: a randomized trial of collaborative care for opioid use disorder and co-occurring depression and/or PTSD. Contemp Clin Trials. 2021;104:106354.
- DePhilippis D, Goodman J, Beamer K, Bloedorn S. Brief addiction monitor (BAM) manual for use in SUD group treatment for non-VA clinicians. 2014. https://www.mentalhealth.va.gov/communityproviders/docs/BAM_in_group_tx_for_NON_VA_5_7_14.pdf. Accessed August 3, 2020.
- NQF 3175. 2019. https://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2019_Measure_468_MIPSCQM.pdf. Accessed July 21, 2020.
- Huhn AS, Dunn KE. Why aren’t physicians prescribing more buprenorphine? J Subst Abuse Treat. 2017;78:1–7.
- Olfson M, Zhang V, Schoenbaum M, King M. Buprenorphine treatment by primary care providers, psychiatrists, addiction specialists, and others. Health Aff. 2020;39(6):984–992.
- McGinty EE, Stone EM, Kennedy-Hendricks A, Bachhuber MA, Barry CL. Medication for opioid use disorder: a national survey of primary care physicians. Ann Intern Med. 2020;173(2):160–162.
- Louie D, Assefa M, McGovern M. Attitudes of primary care physicians toward prescribing buprenorphine: a narrative review. BMC Fam Pract. 2019;20(1):157.
- Fiellin DA, Barry DT, Sullivan LE, et al. A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine. Am J Med. 2013;126(1):74.e11–74.e17.
- Carroll KM, Weiss RD. The role of behavioral interventions in buprenorphine treatment: a review. Am J Psychiatry. 2017;174:738–747.
- Sigmon SC, Ochalek TA, Meyer AC, et al. Interim buprenorphine vs. waiting list for opioid dependence. N Engl J Med. 2016;375(25):2504–2505.
- Wakeman SE, Larochelle MR, Ameli O, et al. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3(2):e1920622.
- National Academies of Science. Engineering and Medicine. Medications for Opioid Use Disorder save Lives. Washington, DC: National Academies Press; 2019.